The Ministry of Health has launched a new service for the first time in Kuwait – genetic testing for patients with amyloidosis,

It is a distinguished service that is provided by a few centers globally, which confirms the keenness of the ministry to improve the quality of services provided by Kuwait, says Al-Anba daily.

Dr. Khaldoun Al-Hamoud, a heart failure consultant at the Chest Diseases Hospital and Vice-President of the National Program for Amyloid Disease at the Ministry of Health, said conducting a genetic examination for patients with Transthyretin (TTR) Cardiac Amyloidosis is the first for Kuwait and is done in cooperation with the Center for Genetic Diseases.

Amyloidosis is the name for a group of rare, serious conditions caused by a build-up of an abnormal protein called amyloid in organs and tissues throughout the body. The build-up of amyloid proteins (deposits) can make it difficult for the organs and tissues to work properly.



Read Today's News TODAY... on our Telegram Channel click here to join and receive all the latest updates t.me/thetimeskuwait